Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer ChemotherapyHironori Fujii, Akio Suzuki, Hisashi Imai et al.|Anticancer Research|2018Cited by 31
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational studyHironori Fujii, Hirotoshi Iihara, Masami Tsuchiya et al.|Supportive Care in Cancer|2024Cited by 1